Active Ingredient: OMEGA-3-CARBOXYLIC ACIDS
Proprietary Name: EPANOVA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDS
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N205060
Product Number: 001
Approval Date: May 5, 2014
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:
Discontinued
Patent and Exclusivity Information
